Skip to content

Application of Self-management Systems Trial (ASSET) across three District Health Board regions in New Zealand: A trial to evaluate the effect of telecare self-management devices on quality of life and change in the use of health services in three populations of people suffering from long term conditions including chronic obstructive pulmonary disease, congestive heart failure or diabetes.

Three populations of people suffering from long term conditions working with telecare devices in their home to improve their self-management ability, target clinical intervention and reduce unplanned hospital admissions when compared to three groups who receive usual care.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12610000269033
Acronym
ASSET
Enrollment
171
Registered
2010-04-01
Start date
2010-09-01
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Telecare involves monitoring and caring for people at a distance, such as people with long term conditions, who often need more care as their illness progresses. Telecare is a relatively new development in New Zealand and combines self-monitoring, whereby people with long term conditions monitor their symptoms to track progress, modify behaviours, or medications accordingly or assess when to seek help from health professionals. ASSET will assess the effectiveness of a long term condition telecare intervention on Health Related Quality of Life, as assessed using the Short Form 36 (SF36) interview tool through distinct randomised controlled evaluations in Auckland and Counties Manukau as well as a formative and process evaluation of the telecare intervention in Tairawhiti. Participants will be assessed at baseline with follow up at three (immediately post intervention) and six months (three months post intervention). ASSET will aim to test the hypotheses that compared to conventional care in the community, telecare will (i) Increase the health related quality of life (HRQoL) of people with long term conditions; (ii) Increase time between first and subsequent hospital attendance for these people; (iii) Reduce ambulatory sensitive hospitilisations (ASH) rates; (iv) Improve the HRQoL of the primary informal caregiver; (v) Provide an economically more efficient means for the person, family / whanau, providers and funding agency to manage a person’s long term condition; and (vi) Increase client and family / whanau satisfaction and sense of control. Participating patients are invited to include family/whanau.

Interventions

At the discretion of their health professional, patients will be given technology to use in their homes to monitor their vital statisitics, and have this data then transmitted to a database for clinicians to review and action as necessary. These devices may include such items as a blood pressure cuff and weighing scales, which the intervention group will be asked to use daily for up to 3 months. Patients will receive an initial triaining session, and a follow up session, on how to use the equip

At the discretion of their health professional, patients will be given technology to use in their homes to monitor their vital statisitics, and have this data then transmitted to a database for clinicians to review and action as necessary. These devices may include such items as a blood pressure cuff and weighing scales, which the intervention group will be asked to use daily for up to 3 months. Patients will receive an initial triaining session, and a follow up session, on how to use the equipment, once they have consented.

Sponsors

Ministry of Health
Lead SponsorGovernment body

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Prevention
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
16 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Age 16+, living permanently at home, expected to be available for 3 months, expected to survive study period, able to communicate in English (or someone in household able to translate), able to physically manage the equipment (or someone available to assist), for the Counties Manukau cohort - must suffer with chronic obstructive pulmonary disease, for the Auckland cohort - must suffer from congestive heart failure, for the Ngati Porou Hauroa cohort - must suffer from diabetes or one of the above disease states.

Exclusion criteria

Previously used structured and monitored/managed telecare

Outcome results

None listed

Source: ANZCTR · Data processed: Mar 13, 2026